Home Cart Sign in  
Chemical Structure| 1062169-56-5 Chemical Structure| 1062169-56-5

Structure of WYE-354
CAS No.: 1062169-56-5

Chemical Structure| 1062169-56-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

WYE-354 is an ATP-competitive inhibitor of mammalian target of rapamycin (mTOR) with an IC50 of 5 nM. It also inhibits PI3Kα and PI3Kγ with IC50 values of 1.89 μM and 7.37 μM, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of WYE-354

CAS No. :1062169-56-5
Formula : C24H29N7O5
M.W : 495.53
SMILES Code : O=C(N1CCC(N2N=CC3=C(N4CCOCC4)N=C(C5=CC=C(NC(OC)=O)C=C5)N=C32)CC1)OC
MDL No. :MFCD18074514
InChI Key :IMXHGCRIEAKIBU-UHFFFAOYSA-N
Pubchem ID :44219749

Safety of WYE-354

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of WYE-354

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • mTOR

    mTOR, IC50:5 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
T. brucei brucei 0.58 µM not mentioned WYE-354 showed modest activity against T. brucei brucei. PMC3160303
Leishmania major promastigotes 4.1 µM not mentioned WYE-354 showed modest activity against Leishmania major promastigotes. PMC3160303
MCF7 0.644 μM 72 h WYE-354 effectively inhibited MCF7 cell proliferation with an IC50 of 0.644 mmol/L. PMC11873659
MDA-MB-231 1.908 μM 72 h WYE-354 effectively inhibited MDA-MB-231 cell proliferation with an IC50 of 1.908 mmol/L. PMC11873659

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice TG221 transgenic mice Oral 10 mg/kg Daily for 3 weeks WYE-354 exhibited comparable anti-tumor activity to miR-199a-3p in the TG221 mouse model, indicating the importance of the MTOR pathway in tumor development. PMC5992479
Nude mice MDA-MB-231 xenograft model Intraperitoneal injection 1, 3, 10 mg/kg Daily for 15 days WYE-354 significantly inhibited tumor growth in the MDA-MB-231 xenograft model, with tumor weight inhibition rates of 28.3%, 55.4%, and 76.6% and tumor volume inhibition rates of 30.7%, 60.0%, and 79.5% at doses of 1, 3, and 10 mg/kg, respectively. PMC11873659

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.02mL

0.40mL

0.20mL

10.09mL

2.02mL

1.01mL

20.18mL

4.04mL

2.02mL

References

 

Historical Records

Categories